12-49034911-T-C
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_003482.4(KMT2D):c.10256A>G(p.Asp3419Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00208 in 1,614,010 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D3419Y) has been classified as Likely benign.
Frequency
Consequence
NM_003482.4 missense
Scores
Clinical Significance
Conservation
Publications
- choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndromeInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
- Kabuki syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00152 AC: 231AN: 152204Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00159 AC: 396AN: 249262 AF XY: 0.00169 show subpopulations
GnomAD4 exome AF: 0.00214 AC: 3128AN: 1461688Hom.: 11 Cov.: 33 AF XY: 0.00219 AC XY: 1590AN XY: 727124 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00152 AC: 231AN: 152322Hom.: 1 Cov.: 32 AF XY: 0.00157 AC XY: 117AN XY: 74490 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:7
- -
- -
- -
- -
- -
- -
KMT2D: BS1 -
not specified Benign:2Other:1
- -
- -
- -
Kabuki syndrome 1 Benign:1Other:1
- -
GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Kabuki syndrome Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at